UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 181

Sortiert nach

D374Y mutation in the PCSK-9 gene in Turkish patients with familial hypercholesterolemia: Long term follow-up with good clinical course

Atherosclerosis, 2016-09, Vol.252, p.e36-e36

2016

Volltextzugriff (PDF)

Clinical management and quality of life in patients with homozygous familial hypercholesterolemia undergoing lipid-apheresis in Turkey: First results of a nation-wide survey (a-hit registry)

Atherosclerosis, 2016-09, Vol.252, p.e46-e47

2016

Volltextzugriff (PDF)

The benefit of salt restriction in the treatment of end-stage renal disease by haemodialysis

Nephrology, dialysis, transplantation, 2009-03, Vol.24 (3), p.956-962

2009

Volltextzugriff (PDF)

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

European heart journal, 2016-10, Vol.37 (39), p.2999-3058

2016

Volltextzugriff (PDF)

First PCSK-9 mutant patient in Turkey

Atherosclerosis, 2016-09, Vol.252, p.e37-e37

2016

Volltextzugriff (PDF)

A survey on awareness cardiovascular mortality in women

Atherosclerosis, 2023-08, Vol.379, p.S199

2023

Volltextzugriff (PDF)

Blood pressure control and knowledge of target blood pressure in coronary patients across Europe: results from the EUROASPIRE III survey

Journal of hypertension, 2011-08, Vol.29 (8), p.1641-1648

2011

Volltextzugriff (PDF)

Benefits of statin treatment in cardiac syndrome-X

European heart journal, 2003-11, Vol.24 (22), p.1999-2005

2003

Volltextzugriff (PDF)

Non-HDL-cholesterol is a better marker of atherogenic dyslipidemia in obstructive sleep apnea

Atherosclerosis, 2022-08, Vol.355, p.24-25

2022

Volltextzugriff (PDF)

P.4.a.002 Heart rate variability in drug naive panic disorder patients compared with healthy controls

European neuropsychopharmacology, 2013-10, Vol.23, p.S508-S508

2013

Volltextzugriff (PDF)

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

European heart journal, 2020, Vol.41 (1), p.111

2020

Volltextzugriff (PDF)

Clinical and Prognostic Significance of Heart Rate Variability in Pulmonary Hypertension

The Journal of heart and lung transplantation, 2014-04, Vol.33 (4), p.S229-S229

2014

Volltextzugriff (PDF)

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

European heart journal, 2020-01, Vol.41 (1), p.111-188

2020

Volltextzugriff (PDF)

PM245 Correlation of Right Ventricle Free Wall Strain and Right Heart Catheterization in Pulmonary Arterial Hypertension

Global heart, 2016-06, Vol.11 (2), p.e112-e112

2016

Volltextzugriff (PDF)

Consensus panel about implementation of guidelines on lipid-lowering management after acute coronary syndrome and up to one year follow-up

Atherosclerosis, 2023-08, Vol.379, p.S81-S82

2023

Volltextzugriff (PDF)

Rationale and design of implement for life study: A validation study of a national lipid lowering strategy after acute coronary syndrome

Atherosclerosis, 2023-08, Vol.379, p.S86-S87

2023

Volltextzugriff (PDF)

A study designed to determine the status of attitudes and behaviors of physicians towards atherosclerosis and dyslipidemia in different clinics across Turkey

Atherosclerosis, 2023-08, Vol.379, p.S89

2023

Volltextzugriff (PDF)

Event-free familial hypercholesterolemia in the elderly: A retrospective analysis of the characteristics and clinical contributors

Atherosclerosis, 2023-08, Vol.379, p.S50

2023

Volltextzugriff (PDF)

Inadequate awareness and attention to non-HDL cholesterol: Undertreatment of high-risk patients in cardiology practice

Atherosclerosis, 2023-08, Vol.379, p.S96

2023

Volltextzugriff (PDF)

PS163 Tenascin-C Levels and Clinical Importance in Pulmonary Arterial Hypertension Associated With Congenital Heart Disease

Global heart, 2016-06, Vol.11 (2), p.e40-e41

2016

Volltextzugriff (PDF)

Management of patients with LDL-cholesterol levels >190mg/dl (4.9mmol/l) in Turkey: An analysis based on Delphi panel approach

Atherosclerosis, 2022-08, Vol.355, p.113

2022

Volltextzugriff (PDF)

Hospitalization features and mortality rates of very high-risk patients with dyslipidemia in Turkey

Atherosclerosis, 2022-08, Vol.355, p.114

2022

Volltextzugriff (PDF)

Distribution of cardiovascular risk among patients with dyslipidemia in Turkey: Results from a Delphi panel

Atherosclerosis, 2022-08, Vol.355, p.112-113

2022

Volltextzugriff (PDF)

First diagnosis and follow up features of patients with dyslipidemia in Turkey

Atherosclerosis, 2022-08, Vol.355, p.114

2022

Volltextzugriff (PDF)

Management of secondary prevention patients with LDL-cholesterol levels < 70mg/dl (1.8mmol/l): An analysis based on Delphi panel approach

Atherosclerosis, 2022-08, Vol.355, p.113

2022

Volltextzugriff (PDF)

1 – 25 von 181

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(155)
Mit Volltextzugriff
(165)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(109)
Life Sciences & Biomedicine
(102)
Humans
(81)
Female
(63)
Biological And Medical Sciences
(50)
Adult
(49)
Medical Sciences
(49)
Middle Aged
(46)
Male
(41)
Surgery
(37)
Cardiovascular System & Cardiology
(28)
Cardiac & Cardiovascular Systems
(26)
Aged
(20)
Follow-Up Studies
(17)
Obstetrics & Gynecology
(15)
Animals
(14)
Prospective Studies
(13)
Retrospective Studies
(13)
Risk Factors
(13)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

D374Y mutation in the PCSK-9 gene in Turkish patients with familial hypercholesterolemia: Long term follow-up with good clinical course

Clinical management and quality of life in patients with homozygous familial hypercholesterolemia undergoing lipid-apheresis in Turkey: First results of a nation-wide survey (a-hit registry)

The benefit of salt restriction in the treatment of end-stage renal disease by haemodialysis

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

First PCSK-9 mutant patient in Turkey

A survey on awareness cardiovascular mortality in women

Blood pressure control and knowledge of target blood pressure in coronary patients across Europe: results from the EUROASPIRE III survey

Benefits of statin treatment in cardiac syndrome-X

Non-HDL-cholesterol is a better marker of atherogenic dyslipidemia in obstructive sleep apnea

P.4.a.002 Heart rate variability in drug naive panic disorder patients compared with healthy controls

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

Clinical and Prognostic Significance of Heart Rate Variability in Pulmonary Hypertension

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

PM245 Correlation of Right Ventricle Free Wall Strain and Right Heart Catheterization in Pulmonary Arterial Hypertension

Consensus panel about implementation of guidelines on lipid-lowering management after acute coronary syndrome and up to one year follow-up

Rationale and design of implement for life study: A validation study of a national lipid lowering strategy after acute coronary syndrome

A study designed to determine the status of attitudes and behaviors of physicians towards atherosclerosis and dyslipidemia in different clinics across Turkey

Event-free familial hypercholesterolemia in the elderly: A retrospective analysis of the characteristics and clinical contributors

Inadequate awareness and attention to non-HDL cholesterol: Undertreatment of high-risk patients in cardiology practice

PS163 Tenascin-C Levels and Clinical Importance in Pulmonary Arterial Hypertension Associated With Congenital Heart Disease

Management of patients with LDL-cholesterol levels >190mg/dl (4.9mmol/l) in Turkey: An analysis based on Delphi panel approach

Hospitalization features and mortality rates of very high-risk patients with dyslipidemia in Turkey

Distribution of cardiovascular risk among patients with dyslipidemia in Turkey: Results from a Delphi panel

First diagnosis and follow up features of patients with dyslipidemia in Turkey

Management of secondary prevention patients with LDL-cholesterol levels < 70mg/dl (1.8mmol/l): An analysis based on Delphi panel approach

Suchergebnisse filtern